Kailera Therapeutics shares surge 62.5% in Nasdaq debut
Investing.com Gold reports: Kailera Therapeutics shares surge 62.5% in Nasdaq debut. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Kailera Therapeutics shares surge 62.5% in Nasdaq debut. Full body text was unavailable at ingest time, so this brief is based on headline context.